Search Results for "guidelines"

ONS member Marcia Beck, ACNS-BC, CLT-LANA, clinical nurse coordinator of lymphedema at the University of Kansas Health System in Kansas City and member of the ONS Greater Kansas City Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the ONS Guideline™ for the Management of Cancer Treatment-Related Lymphedema. Marcia  was a member of the panel that developed the guidelines, which published in September 2020. 

Pamela Ginex, EdD, MPH, RN, OCN^®, ONS senior manager of evidence-based practice and inquiry, joins Chris Pirschel, ONS staff writer/producer, to discuss the Society’s new symptom management guidelines, the process by which the guidelines were developed, and how they’ll influence practice for nurses and clinicians throughout the oncology community.

ONS member George Ebanks, RN, BSN, OCN^®, medical oncology nurse in the cutaneous oncology program at Moffitt Cancer Center in Tampa, FL, and member of the Greater Tampa ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss managing cancer treatment-related skin toxicity. George was also on the panel that developed the ONS Guidelines for skin toxicities, which published in September 2020.   

ONS member Lauren Suarez, RN, MSN, OCN^®, CBCN^®, nurse manager of radiation oncology at Miami Cancer Institute in Florida and member of the Miami-Dade ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the ONS Guidelines™ for Cancer Treatment–Related Radiodermatitis and how oncology nurses can manage this treatment side effect. Suarez was also a member of the advisory panel that developed this clinical practice guideline, which published in November 2020.

ONS member Deborah Thorpe, PhD, APRN, founder of and nurse supervisor at the Inn Between assisted living in Salt Lake City, UT, and member of the Intermountain ONS Chapter, joins Steph Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the ONS Guidelines™ for Opioid-Induced and Non–Opioid-Related Cancer Constipation, which published in November 2020. 

ONS member MiKaela Olsen, DNP, APRN-CNS, AOCNS^®, FAAN, clinical nurse specialist in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital and Greenspring Oncology in Baltimore, MD, and member of the Mid-Chesapeake Bay Chapter ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss extravasation of antineoplastic agents used in cancer care and what oncology nurses need to know about administering vesicant chemotherapy. Olsen was the lead editor of the ONS Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice. 

“Saline is very benign and doesn’t have any risk of harm for the patient. They’re small doses, so we’re not worried about sodium or anything. The risk of heparin is actually quite extensive,” MiKaela Olsen, DNP, APRN-CNS, AOCNS^®, FAAN, clinical program director in oncology at Johns Hopkins Hospital and Johns Hopkins Health System in Baltimore, MD, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, during a conversation about the latest evidence surrounding central venous catheter flushing solutions and techniques. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below.

ONS member Abigail Baldwin Medsker, MSN, RN, OCN^®, associate director of digital transformation at Memorial Sloan Kettering Cancer Center in New York and member of the ONS New York City Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss best practices in telehealth, commonly used strategies, and resources for oncology nurses and patients navigating cancer care in a digital world. 

ONS member Marcelle Kaplan, MS, RN, a breast oncology clinical nurse specialist, and a member of the panel that developed the ONS Guidelines for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer, and member of the ONS Long Island/Queens Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss ONS's new guidelines and what nurses need to know about the different interventions for managing hot flashes.

ONS’s Pamela Ginex, EdD, MPH, RN, OCN^®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educating oncology nurses about immunotherapy-related side effects, as well as the new resources available for providers and patients.